Basic Information
Basic information for C5orf64-225-13aa-1
Peptide Name C5orf64-225-13aa-1
Genome Position chr5:61704071-61704109[+]
Species Human
Peptide Sequence MELQFLPNRNPPW
Peptide Length 13
Unique No (C5orf64-201-13aa-2,C5orf64-202-13aa,C5orf64-203-13aa-2,C5orf64-210-13aa-1,C5orf64-211-13aa-2,C5orf64-213-13aa-2,C5orf64-215-13aa-1,C5orf64-219-13aa)
Grand Average of Hydropathicity -0.9154
Relative Molecular Mass 1858.07
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000668865;C5orf64-225
Transcript Length 2900
Coding Ability 0.4476
DNA Sequence Corresponding to Peptide ATGGAGTTGCAGTTCTTGCCTAACAGGAACCCACCATGG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :